News

Reports: Valeant, Actavis deal put on hold

BY Alaric DeArment

NEW YORK — A proposal by Canadian drug maker Valeant Pharmaceuticals International to purchase generic drug maker Actavis has fallen through, according to published reports.

According to reports, Valeant was planning to pay more than $13 billion in stock to acquire Actavis, but the deal was put on hold because the companies could not agree to terms of the deal. The deal would create a company worth about $35 billion.

Actavis became the world’s third-largest maker of generic drugs last year when U.S.-based Watson Pharmaceuticals acquired Switzerland-based Actavis. The company announced in January that it would change its name to Actavis.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

CRN: Consumer Reports corrects article on vitamin D

BY Michael Johnsen

WASHINGTON — Consumer Reports recently corrected a story to run in its May issue, titled “Vitamin D: How 32 supplements really measure up," that erroneously identified nine vitamin D/calcium supplement products that the publication claimed exceeded the California Proposition 65 Lead Limit for Reproductive Risk.

The story has been corrected online and now states that “All [of the adult calcium plus Vitamin D supplement products tested] met our quality criteria, which includes meeting label claims of calcium and vitamin D, passing USP dissolution test and not exceeding USP limits for heavy metals.”

“We believe this was an honest mistake by the publication, as the settlement agreements with the State of California are not available on either the California Attorney General’s website or the California Office of Environmental Health Hazard Assessment’s website, and we were glad to see the correction," noted Steve Mister, president and CEO for the Council for Responsible Nutrition, in a release last week. “As importantly as the explanation that the companies were not breaking the law is the fact that consumers need to be reassured that the lead levels do not pose a safety risk."

Even before the correction, the article overall provided positive news for vitamin D and calcium supplement users, Mister noted. 

 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

SheaMoisture develops new facial masks

BY Antoinette Alexander

AMITYVILLE, N.Y. — SheaMoisture has introduced its new all-natural and organic facial masks that promise to give dull, dry skin a boost of instant vitality.
 
Coconut & Hibiscus Facial Mask – Designed to improve skin’s radiance with hibiscus flower and songyi mushroom extracts. A blend of mineral-rich clays aims to promote the elimination of impurities, softens and detoxifies dull complexions. Coconut oil and shea butter hydrate, protect against moisture loss and promote a healthy, youthful glow.
 
Raw Shea Butter Facial Mask – Features a blend of organic raw shea butter and mineral-rich clays to purify and soften, while improving skin’s vivacity, the company stated. The mask is meant to be a non-drying mask and gently clarifies skin while hydrating and promoting moisture. Therapeutic extracts of frankincense, myrrh and anti-oxidant vitamin E are designed to boost skin’s rejuvenation.
 
How to use: Apply to clean, dry skin once or twice a week as needed. Allow to set for five to 10 minutes, then rinse with cool water. Avoid eye area.  Pat skin dry prior to applying moisturizer.
 
Each mask has a suggested retail price of $9.99 and is available at select Target stores nationwide.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES